Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.22.0.1
Equity (Tables)
 6 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of sales through equity offering program
Three months ended   Avg price
per share		     Number of
Shares		     Gross
Proceeds
(in millions)		     Offering
Expenses
(in millions)  		     Net
Proceeds
(in millions)		  
September 30, 2021   $ 9.99       555,455     $ 5.5     $ 0.1     $ 5.4  
December 31, 2021   $ 7.04       1,931,022     $ 13.6     $ 0.2     $ 13.4  
Total   $ 7.70       2,486,477     $ 19.1     $ 0.3     $ 18.8  

 
Schedule of black-scholes option pricing model with weighted average assumptions
    Six Months
Ended
December 31,
2021		  
Exercise price   $ 6.76 –10.15  
Expected term (years)     4.75 – 5.00  
Volatility     66-67 %
Risk-free interest rate     0.76%–1.14 %
Dividend yield     0 %
Weighted Average Grant Date Fair Value of Options granted during the period   $ 5.23  

  
Schedule of stock-based compensation expense
    Three Months Ended
December 31,		     Six Months Ended
December 31,		  
    2021     2020     2021     2020  
Research and Development   $ 1,716     $ 928     $ 2,948     $ 1,942  
General and Administrative     1,184       1,138       2,300       2,151  
Total   $ 2,900     $ 2,066     $ 5,248     $ 4,093  

 
Schedule of unrecognized stock-based compensation expense and weighted-average years
    As of December 31, 2021  
    Unrecognized
stock-based
compensation		     Weighted-
average years
to be recognized		  
Options   $ 4,082       2.53  
Restricted stock units   $ 12,271       2.37